Cargando...
Stability of an Extemporaneously Compounded Oral Suspension of Bosentan
Purpose: To assess the stability of an extemporaneously compounded oral suspension of bosentan from commercially available tablets for a period of 1 month. Methods: A 6.25 mg/mL oral suspension of bosentan monohydrate was prepared from Tracleer tablets. The bosentan suspension was then evenly divide...
Gardado en:
| Publicado en: | Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Thomas Land Publishers, Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896348/ https://ncbi.nlm.nih.gov/pubmed/27303093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5105-389 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|